RA
AHCO icon

Royce & Associates’s AdaptHealth AHCO Stock Holding History

Royce & Associates’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,079,905
Closed -$10.2M – 764
2025
Q2 		$10.2M Buy
1,079,905
+113,830
+12% +$1M 0.1% 285
2025
Q1 		$10.5M Sell
966,075
-36,680
-4% -$369K 0.11% 272
2024
Q4 		$9.55M Buy
1,002,755
+225,350
+29% +$2.28M 0.09% 335
2024
Q3 		$8.73M Buy
777,405
+92,740
+14% +$986K 0.08% 345
2024
Q2 		$6.85M Buy
684,665
+99,781
+17% +$1.01M 0.06% 414
2024
Q1 		$6.73M Buy
+584,884
New +$4.97M 0.06% 434

Other funds holding AHCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates's AHCO Position: Q3 2025 in Review

Royce & Associates sold out of AdaptHealth (AHCO) in Q3 2025, closing a stake of 1,079,905 shares — an estimated $10.2M sold.

Royce & Associates first reported a position in AHCO in Q1 2024 and held it in 6 quarters. The position peaked at $10.5M in Q1 2025. 225 funds tracked by Wall St. Rank hold AHCO as of Q3 2025.

  • Royce & Associates reported no remaining AdaptHealth position as of Q3 2025 after selling out during the quarter.
  • Royce & Associates sold 1,079,905 AdaptHealth shares in Q3 2025, an estimated $10.2M.
  • Royce & Associates first reported a position in AdaptHealth in Q1 2024 and held it in 6 quarters.
  • Royce & Associates's AdaptHealth position peaked at $10.5M in Q1 2025.
  • 225 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2025.

Based on Royce & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.